Impact of regular physical activity on weekly warfarin dose requirement
暂无分享,去创建一个
Jason Hu | J. Tardif | M. Dubé | M. Talajic | P. Shahabi | I. Mongrain | S. Perreault | S. Provost | S. Dumas | É. Rouleau-Mailloux | Nawal Bouchama | Yassamin Feroz Zada | Jacqueline V. Nguyen | J. Nguyen | Étienne Rouleau-Mailloux
[1] N. Limdi,et al. Influence of Regular Physical Activity on Warfarin Dose and Risk of Hemorrhagic Complications , 2014, Pharmacotherapy.
[2] J. Tardif,et al. Validation of patient‐reported warfarin dose in a prospective incident cohort study , 2014, Pharmacoepidemiology and drug safety.
[3] Kristin J. Heumann,et al. Validity and Reliability of the Global Physical Activity Questionnaire (GPAQ) , 2013 .
[4] H. Chao,et al. The influence of running exercise training on pharmacokinetics of meloxicam in rats , 2013 .
[5] E. Arredondo,et al. Validity of the Global Physical Activity Questionnaire (GPAQ) in adult Latinas. , 2012, Journal of physical activity & health.
[6] M. Whirl‐Carrillo,et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing , 2011, Clinical pharmacology and therapeutics.
[7] T. Lenz. The effects of high physical activity on pharmacokinetic drug interactions , 2011, Expert opinion on drug metabolism & toxicology.
[8] F. Bull,et al. Global physical activity questionnaire (GPAQ): nine country reliability and validity study. , 2009, Journal of physical activity & health.
[9] Daniel E Jonas,et al. Genetic and clinical factors relating to warfarin dosing. , 2009, Trends in pharmacological sciences.
[10] J. Jansson,et al. Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics , 2007, Scandinavian journal of primary health care.
[11] Mark A Hlatky,et al. Practice of Epidemiology Validation of a New Brief Physical Activity Survey among Men and Women Aged 60 – 69 Years , 2006 .
[12] D. Newman,et al. The prevalence of nontherapeutic and dangerous international normalized ratios among patients receiving warfarin in the emergency department. , 2006, Annals of emergency medicine.
[13] S. Goldhaber,et al. Major bleeding complications in a specialized anticoagulation service. , 2005, The American journal of cardiology.
[14] David B. Matchar,et al. Relationship Between Test Frequency and Outcomes of Anticoagulation: A Literature Review and Commentary with Implications for the Design of Randomized Trials of Patient Self-Management , 2000, Journal of Thrombosis and Thrombolysis.
[15] M. Faulkner,et al. Potential Interactions between Exercise and Drug Therapy , 2004, Sports medicine.
[16] A. Persky,et al. A review of the effects of chronic exercise and physical fitness level on resting pharmacokinetics. , 2003, International journal of clinical pharmacology and therapeutics.
[17] Y. Tam,et al. The effects of exercise on the pharmacokinetics of drugs. , 2000, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[18] T. Baglin,et al. Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment. , 2000, Blood.
[19] G. Aithal,et al. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications , 1999, The Lancet.
[20] M. Takinami,et al. Influence of Physical Activity on Warfarin Therapy , 1998, Thrombosis and Haemostasis.
[21] B. Honoré,et al. Influence of Fatty Acids on the Binding of Warfarin and Phenprocoumon to Human Serum Albumin with Relation to Anticoagulant Therapy , 1996, The Journal of pharmacy and pharmacology.
[22] M. V. van Baak. Influence of exercise on the pharmacokinetics of drugs. , 1990, Clinical pharmacokinetics.
[23] F. G. Larsen,et al. Warfarin binding to plasma albumin, measured in patients and related to fatty acid concentrations , 1986, European journal of clinical investigation.
[24] M. Døssing. Effect of Acute and Chronic Exercise on Hepatic Drug Metabolism , 1985, Clinical pharmacokinetics.
[25] A. A. Spector,et al. INFLUENCE OF FREE FATTY ACID CONCENTRATION ON DRUG BINDING TO PLASMA ALBUMIN * , 1973, Annals of the New York Academy of Sciences.